Strive Health Recognized by TIME as One of the World’s Top HealthTech Companies for a Second Consecutive Year

DENVER--(BUSINESS WIRE)--Strive Health, the leading U.S. value-based kidney care company, was named one of the World’s Top HealthTech Companies by TIME and Statista Inc. for a second consecutive year. The full award list can be viewed on Time.com.

The World’s Top HealthTech Companies 2026 ranking recognizes leading innovators that are advancing healthcare with the support of technology. Out of thousands of healthcare technology companies reviewed, the top 500 were honored. Companies were evaluated based on three primary data sources: financial performance metrics, reputation analysis and online engagement.

“This TIME recognition reflects the work the entire Strive Health team is doing to make kidney care simpler, more connected and patient-centered,” said Tom Hawkes, Chief Technology Officer at Strive Health. “By bringing together data and insights, our technology enables care teams and provider partners to spend less time searching for information and more time delivering proactive, personalized support to people living with kidney disease.”

Strive Health’s technology connects clinical data, care teams, specialty partners and PCPs to support more coordinated kidney care. It gives providers timely insights and makes referrals, updates and follow-through more seamless across the care network, helping clinicians identify changing needs sooner and connect patients to the right care.

Today, Strive Health serves more than 165,000 patients across all 50 states, partners with over 6,500 providers and has $5.5 billion of medical spend under management.

The company’s strong clinical outcomes were recently published in two evidence-based, peer-reviewed journals. A study of Strive Health’s Transitions of Care Management program, published in the Journal of Patient Experience, found that the program was associated with 42%, 37%, and 25% lower hospital readmission rates at 7, 14, and 30 days, respectively. Strive Health’s study published in The American Journal of Managed Care that focused on eGFR — a calculation used to check how well the kidneys are filtering waste from the blood — showed a 77% slower decline in stage 3b chronic kidney disease (CKD) and a 65% slower decline in stage 4 CKD.

To date, Strive Health has been recognized with more than 15 awards, including LinkedIn Top Startup in Denver, Built In Best Companies, CB Insights 50 Most Promising Digital Health Companies and more.

ABOUT STRIVE HEALTH

Strive Health is the nation’s leader in value-based kidney care and partner of choice for innovative healthcare payors and providers. Using a unique combination of technology — including AI — care interventions and seamless integration with local providers, Strive forms an integrated care delivery system that supports the entire patient journey from chronic kidney disease (CKD) to end-stage kidney disease (ESKD). To help patients, Strive partners with commercial and Medicare Advantage payors, Medicare, health systems and physicians through flexible value-based payment arrangements, including risk-based programs. Strive serves over 165,000 people with CKD and ESKD across 50 states and partners with over 6,500 providers. Strive’s case management and population health programs are accredited by the National Committee for Quality Assurance (NCQA), and its technology platform, CareMultiplier™, is certified by HITRUST. To learn more, visit  StriveHealth.com.